Position in AZN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,315,025,873
New position
Shares Held
6,667,812
first reported quarter
Ownership
0.430%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 96.35024202841952.ToString("F0")%
Shared 0.16831608329688957.ToString("F0")%
None 3.4814418882835927.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $22,910,045,373 across 16 Drug Manufacturers - General names. AZN ranks #9 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,821,962 | $5,334,160,377 | |
| 2 | LLY |
ELI LILLY & Co
|
4,860,408 | $4,470,457,455 | |
| 3 | ABBV |
AbbVie Inc.
|
13,278,161 | $2,887,867,228 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,713,363 | $2,251,030,425 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,053,151 | $2,097,957,640 | |
| 6 | PFE |
Pfizer Inc
|
53,879,900 | $1,512,947,580 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,301,337 | $1,413,226,077 | |
| 8 | AMGN |
Amgen Inc
|
3,793,443 | $1,334,722,908 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,315,025,873 | 6,667,812 | Shares | Defined | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||